Impact of Age on Hormonal Profiles of Sub-Fertile Women Attending Fertility Clinic in Umuahia, Abia State, South Eastern Nigeria — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Impact of Age on Hormonal Profiles of Sub-Fertile Women Attending Fertility Clinic in Umuahia, Abia State, South Eastern Nigeria
Department of Medical Laboratory Science, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Nigeria
,
Department of Medical Laboratory Services, Federal Medical Center, Umuahia, Abia State, Nigeria
,
Department of Biochemistry, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Nigeria
,
Department of Medical Laboratory Science, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Nigeria
1 Department of Medical Laboratory Science, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Nigeria
2 Department of Medical Laboratory Services, Federal Medical Center, Umuahia, Abia State, Nigeria
3 Department of Biochemistry, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Nigeria
4 Department of Medical Laboratory Science, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Nigeria
Aim: This study evaluated the impact of age on the hormonal profiles of women diagnosed with infertility in a Fertility Clinic in Abia State, South-East, Nigeria. Methodology: Subjects comprised of 200 females: 150 subjects and 50 controls, aged < 20 and up to 49 years, stratified into age < 20 years (control), age 20 - 29 years (group 1), age 30 - 39 years (group 2) and age 40 - 49 years (group 3). About 5 ml of blood samples for anti-Mullerian, follicle stimulating, luteinizing, estradiol, and prolactin hormones determinations were collected on day 2 - 3 of spontaneous menstrual cycle from all groups and control and analyzed using enzyme-linked immunosorbent assay. The FSH/LH ratio of all groups was also calculated. The data were analyzed statistically and values considered significant at p < 0.05. Result: The means ± SEM of serum anti-Mullerian hormones were 1602.44 ± 54.42 pg/ml (control), 848.06 ± 23.04 pg/ml (group 1), 26.74 ± 1.28 pg/ml (group 2), 10.37 ± 1.26 pg/ml (group 3) values for follicle stimulating hormone in the control subjects was 4.90 ± 0.22 mIU/ml, 12.59 ± 0.79 mIU/ml (group 1), 30.59 ± 1.31 mIU/ml (group 2), and 41.59 ± 1.59 miU/ml (group 3). Similarly, the mean ± SEM of luteinizing hormone of control, group 1, group 2 and group 3 were 5.01 ± 0.22 mIU/ml, 15.02 ± 1.13 mIU/ml, 42.71 ± 1.82 mIU/ml and 58.22 ± 2.62 mIU/ml respectively while for estadiol the values were 63.16 ± 1.95 pg/ml, 94.10 ± 5.56 pg/ml, 58.84 ± 4.01 pg/ml and 36.7 ± 1.59 pg/ml for control, group 1, group 2 and group 3 respectively. The mean ± SEM of FSH/LH ratio for the control and experimental subjects were 0.98 ± 0.01, 0.89 ± 0.02, 0.74 ± 0.03 and 0.75 ± 0.02 for control, group 1, group 2 and group 3 respectively. The comparison of the means showed significant difference (p < 0.0001). The hormonal parameters were also positively and negatively correlated amongst each. Conclusion: The evaluation of levels of the hormonal parameters across the age ranges of the population studied shows that women within the control and experimental group 1 (<20 years and 20 - 29 years) have a better chance of achieving pregnancy naturally.
(2010) National Guideline Clearinghouse Fertility: Assessment and Treatment for People with Fertility Problems. http://www.rcog.org.uk/womens-health/clinical-guidance/fertility-assessment-and-treatment-people-fertility-problems
Menuba, I.E., Ugwu, E.O., Obi, S.N., Lawani, L.O. and Onwuka, C.I. (2014) Clinical Management and Therapeutic Outcome of Infertile Couples in Southeast Nigeria. Therapeutics and Clinical Risk Management, 10, 763-768. https://doi.org/10.2147/TCRM.S68726
Okonofua, F.E. and Obi, H. (2009) Specialized versus Conventional Treatment of Infertility in Africa, Time for a Pragmatic Approach. African Journal of Reproductive Health, 13, 9-15.
Ombelet, W., Cooke, I., Dyer, S., Serour, G. and Devroey, P. (2008) Infertility and the Provision of Infertility Medical Services in Developing Countries. Human Reproduction Update, 14, 605-621. https://doi.org/10.1093/humupd/dmn042
Okohue, J.E., Onuh, S.O. and Ikimalo, J.I. (2013) Comparison of IVF/ICSI Outcome in Patients with Polcystic Ovarian Syndrome or Tubal Factor Infertility. Nigerian Journal of Clinical Practice, 16, 207-210. https://doi.org/10.4103/1119-3077.110164
Omoaregba, J.O., James, B.O., Lawani, A.O., Morakinya, O. and Olotu, O.S. (2011) Psychosocial Characteristics of Female Infertility in a Tertiary Health Institution in Nigeria. Annals of African Medicine, 10, 19-24. https://doi.org/10.4103/1596-3519.76567
Alvarez Nieto, C. (2006) Infertility: The Magnitude of This Problem. Revista de Enfermeria, 29, 56-62.
Garcia, J.E. and Nelson, L.H. (2019) Infertility. http://www.emedicine.com/med
Umeora, O.U., Ejikeme, B.N., Sunday-Adeoye, I. and Umeora, M.C. (2008) Sociocultural Impediments to Male Factor Infertility Evaluation in Rural Southeast Nigeria. Journal of Obstetrics and Gynaecology, 28, 23-36. https://doi.org/10.1080/01443610802044908
van Balen, F. and Bos, H.M. (2009) The Social and Cultural Consequences of Being Childless in Poor-Resource Countries. Facts, Views & Vision in ObGyn, 1, 106-121.
Dyer, S.J., Abraham, N., Mokoena, N.E., Lamard, C.J. and van der Spury, Z.M. (2005) Psychological Distress among Women Suffering from Couple Infertility in South Africa: A Quantitative Assessment. Human Reproduction, 20, 1938-1943. https://doi.org/10.1093/humrep/deh845
Cong, J., Li, P., Zheng, L. and Tan, J. (2016) Prevalence and Risk Factors of Infertility at a Rural Site of Northern China. PLoS ONE, 11, e0155563. https://doi.org/10.1371/journal.pone.0155563
Unuane, D., Tournaye, H., Velkeniers, B. and Poppe, K. (2011) Endocrine Disorders and Female Infertility. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 861-873. https://doi.org/10.1016/j.beem.2011.08.001
te Velde, E.R. and Pearson, P.L. (2001) The Variability of Female Reproductive Ageing. Human Reproduction Update, 8, 141-154. https://doi.org/10.1093/humupd/8.2.141
Menken, J., Trusell, J. and Larsen, U. (1986) Age and Infertility. Science, 233, 1389-1394. https://doi.org/10.1126/science.3755843
O’Conner, K.A., Holman, D.J. and Wood, J.W. (1998) Declining Fecundity and Ovarian Ageing in Natural Fertility Populations. Maturitas, 30, 127-136. https://doi.org/10.1016/S0378-5122(98)00068-1
Naing, L., Winn, T. and Rusli, B.N. (2006) Practical Issues in Calculating the Sample Size for Prevalence Studies. Archives of Orofacial Sciences, 1, 9-14.
Broer, S.L., Eijkemans, M.J.C., Scheffer, G.J., van Rooij, I.A.J., de Vet, A. and Themmen, A.P.N. (2011) Anti Mullerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normovulatory Women. The Journal of Clinical Endocrinology & Metabolism, 96, 2532-2539. https://doi.org/10.1210/jc.2010-2776
Smotrich, D.B., Widra, E.A. and Gindoff, P.R. (1995) Prognostic Value of Day 3 Estradiol on in Vitro Fertilization Outcome. Fertility and Sterility, 64, 1136-1140. https://doi.org/10.1016/S0015-0282(16)57974-6
Rehman, R., Jawaid, S., Gul, H. and Khan, R. (2014) Impact of Peak Estradiol Levels on Reproductive Outcome of Intracytoplasmic Sperm Injection. Pakistan Journal of Medical Sciences, 30, 986-991. https://doi.org/10.12669/pjms.305.5175
Al-Fahham, A.A. and Al-Nowainy, H.Q. (2016) The Role of FSH, LH, and Prolactin Hormones in Female Infertility. International Journal of PharmTech Research, 6, 110-118.
Sudha, G. and Reddy, K.S.N. (2013) Causes of Female Infertility: A Cross Sectional Study. International Journal of Latest Research in Science and Technology, 2, 119-123.
Huang, K.E., Bonfiglio, T.A. and Muechler, E.K. (1991) Transient Hyperprolactinaemia in Infertile Women with Luteal Phase Deficiency. Obstetrics & Gynecology, 78, 651-655.
Mutlu, M.F. and Erdem, A. (2012) Evaluation of Ovarian Reserve in Infertile Women. Journal of the Turkish-German Gynecological Association, 13, 196-103. https://doi.org/10.5152/jtgga.2012.28
Sowers, M.R., Eyvazzadeh, A.D. and McConnell, D. (2008) Antimullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition. The Journal of Clinical Endocrinology & Metabolism, 93, 3478-3483. https://doi.org/10.1210/jc.2008-0567
Fang, T., Zheng, S., Wang, L., Yuan, P., Li, P., Ouyang, N., Zheng, L. and Wang, W. (2015) Predictive Value of Age-Specific FSH Levels for IVF-ET Outcome in Women with Normal Ovarian Function. Reproductive Biology and Endocrinology, 13, 63. https://doi.org/10.1186/s12958-015-0056-6
Orvieto, R., Meltzer, S., Robinson, J., Gerner, O., Anteby, E.Y. and Nahum, R. (2008) Does Day 3 Luteinizing Hormone Level Predict IVF Success in Patients Undergoing Controlled Ovarian Stimulation with GNRH Analogues. Fertility and Sterility, 90, 1297-1300. https://doi.org/10.1016/j.fertnstert.2007.10.058
Regan, L., Owen, E.J. and Jacobs, H.S. (1990) Hyper Secretion of Luteinizing Hormone, Infertility, and Miscarriage. The Lancet, 336, 1141-1144. https://doi.org/10.1016/0140-6736(90)92765-A
Reinthaller, A., Deutinger, J., Csaicsich, P., Riss, P., Muller-Tyl, E., Fischl, F. and Janisch, H. (1987) Effect of Serum Prolactin on Cycle Stimulation and Fertilization of Human Oocytes. Geburtshilfe und Frauenheilkunde, 47, 246-248. https://doi.org/10.1055/s-2008-1035816
Ekwempu, C.C., Ekwempu, I.A., Adinoyi, A.D., Gofwen, D., Surajudeen, A.J. and Okonkwo, P.O. (2017) Relevance of Serum LH/FSH/Prolactin and Anti Mullerian Hormone Estimation in In-Vitro Fertilization. European Journal of Pharmaceutical and Medical Research, 4, 138-142.
Liu, K. and Greenbalt, E. (2008) Elevated Day 3 Follicle Stimulating Hormone/Luteinizing Hormone Ratio > or = 2 Is Associated with Higher Rates of Cancellation in In Vitro Fertilization, Embryo Transfer Cycles. Fertilization and Sterility, 90, 297-301. https://doi.org/10.1016/j.fertnstert.2007.06.038
Barbakadze, L., Kristesashvili, J., Khonelidze, N. and Tsagareishvili, G. (2015) The Correlations of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Antral Follicle Count in Different Age Groups of Infertile Women. International Journal of Fertility and Sterility, 8, 393-398.
Bala, J., Agrawal, Y., Seth, S., Goyal, V. and Kumar, P. (2014) Correlation between Anti-Müllerian and Follicle-Stimulating Hormone in Female Infertility. International Journal of Health & Allied Sciences, 3, 232-236. https://doi.org/10.4103/2278-344X.143060
de Vet, A., Laven, J.S., de Jong, F.H., Themmen, A.P. and Fauser, B.C. (2002) Antimullerian Hormone Serum Levels: A Putative Marker for Ovarian Aging. Fertility and Sterility, 77, 357-362. https://doi.org/10.1016/S0015-0282(01)02993-4
Burger, H.G., Dudley, E.C., Hopper, J.L., Groome, N., Guthrie, J.R. and Green, A. (1999) Prospectively Measured Levels of Serum Follicle-Stimulating Hormone, Estradiol, and The dimeric Inhibins during the Menopausal Transition in a Population-Based Cohort of Women. The Journal of Clinical Endocrinology & Metabolism, 84, 4025-4030. https://doi.org/10.1210/jcem.84.11.6158
Jamil, Z., Fatima, S.S., Ahmed, K. and Malik, R. (2016) Anti-Mullerian Hormone. Above and Beyond Conventional Ovarian Reserve Markers. Disease Markers, 2016, Article ID: 5246217. https://doi.org/10.1155/2016/5246217
Broekmans, F.J., Kwee, J., Hendriks, D.J., Mol, B.W. and Lambalk, C.B. (2006) A Systemic Review of Test Predicting Ovarian Reserve and IVF Outcome. Human Reproduction Update, 12, 685-618. https://doi.org/10.1093/humupd/dml034
Majumdar, A. and Mangal, N.S. (2013) Hyperprolactinaemia. Journal of Human Reproductive Sciences, 6, 168-175. https://doi.org/10.4103/0974-1208.121400
Mukhejee, T., Copperman, A.B., Lapinski, R., Sandler, B., Bustillo, M. and Grunfeld, L. (1996) An Elevated Day 3 Follicle Stimulating Hormone: Luteinizing Hormoneration (FSH:LH) in the Presence of a Normal Day 3 FSH Predicts a Poor Response to Controlled Ovarian Hyperstimulation. Fertility and Sterility, 65, 588-593. https://doi.org/10.1016/S0015-0282(16)58159-X
Kofinas, J.D. and Elias, R.T. (2014) Follicle-Stimulating Hormone/Luteinizing Hormone Ratio as an Independent Predictor of Response to Controlled Ovarian Stimulation. Women’s Health, 10, 505-509. https://doi.org/10.2217/WHE.14.31